Catalyst Pharmaceuticals Inc (CPRX) — Strategic Asset Allocation Index
Catalyst Pharmaceuticals Inc (CPRX) has a Strategic Asset Allocation Index of 2.7% as of March 2026. Strategic assets (PP&E of $- plus long-term investments of $27.29 Million) total $27.29 Million, measured against net assets of $1.01 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check asset resilience ratio of Catalyst Pharmaceuticals Inc to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Catalyst Pharmaceuticals Inc Strategic Asset Allocation Index (2004–2025)
This chart shows how Catalyst Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 22 annual periods from 2004 to 2025. As of March 2026, the index stands at 2.7%, representing strategic assets of $27.29 Million against net assets of $1.01 Billion USD. See Catalyst Pharmaceuticals Inc leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Catalyst Pharmaceuticals Inc (2004–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Catalyst Pharmaceuticals Inc from 2004 to 2025, covering 22 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Catalyst Pharmaceuticals Inc market cap and net worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 2.4% | $22.54 Million | $- | $22.54 Million | $954.27 Million | ▼ -0.6 pp |
| 2024 | 3.0% | $21.56 Million | $- | $21.56 Million | $727.63 Million | ▼ -1.3 pp |
| 2023 | 4.3% | $16.49 Million | $- | $16.49 Million | $387.88 Million | ▲ +4.0 pp |
| 2022 | 0.3% | $847.00K | $847.00K | $0.00 | $300.42 Million | ▼ -1.6 pp |
| 2021 | 1.9% | $3.98 Million | $3.98 Million | $- | $206.83 Million | ▲ +1.8 pp |
| 2020 | 0.1% | $129.80K | $129.80K | $- | $169.60 Million | ▼ -0.2 pp |
| 2019 | 0.2% | $210.47K | $210.47K | $0.00 | $87.63 Million | ▼ -10.1 pp |
| 2018 | 10.3% | $5.25 Million | $245.43K | $5.01 Million | $50.78 Million | ▲ +10.1 pp |
| 2017 | 0.2% | $191.38K | $191.38K | $- | $80.96 Million | ▼ -0.4 pp |
| 2016 | 0.6% | $244.20K | $244.20K | $- | $39.31 Million | ▲ +0.3 pp |
| 2015 | 0.3% | $191.55K | $191.55K | $- | $55.48 Million | ▲ +0.1 pp |
| 2014 | 0.2% | $71.38K | $71.38K | $- | $35.24 Million | ▲ +0.0 pp |
| 2013 | 0.2% | $40.63K | $40.63K | $- | $21.39 Million | ▼ -0.2 pp |
| 2012 | 0.4% | $53.68K | $53.68K | $- | $14.62 Million | ▲ +0.0 pp |
| 2011 | 0.3% | $12.19K | $12.19K | $- | $3.76 Million | ▼ -0.5 pp |
| 2010 | 0.8% | $45.00K | $45.00K | $- | $5.52 Million | ▼ -0.1 pp |
| 2009 | 0.9% | $68.00K | $68.00K | $- | $7.62 Million | ▼ 0.0 pp |
| 2008 | 0.9% | $96.00K | $96.00K | $- | $10.56 Million | ▲ +0.1 pp |
| 2007 | 0.8% | $128.00K | $128.00K | $- | $16.32 Million | ▲ +0.7 pp |
| 2006 | 0.1% | $20.00K | $20.00K | $- | $19.85 Million | ▼ -0.8 pp |
| 2005 | 0.9% | $4.00K | $4.00K | $- | $446.46K | ▲ +0.0 pp |
| 2004 | 0.9% | $1.00K | $1.00K | $- | $117.58K | — |